AN EVIDENCED-BASED SMART-PHRASE TO IMPROVE DOCUMENTATION OF SUPPORTIVE CARE MEASURES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

SESSION TITLE: Diagnosis and Treatment of IPF SESSION TYPE: Original Investigations PRESENTED ON: 10/20/2019 2:15 PM - 3:15 PM PURPOSE: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause occurring in adults over the age of 50, affecting approximately 5 million people worldwide. Two FDA approved mediations are used to slow progression of the disease process but not all patients can...